US Patent Issued to THE REGENTS OF THE UNIVERSITY OF MICHIGAN on Jan. 20 for "Cysteamine for the treatment, mitigation and prevention of coronaviral, e.g., SARS-CoV-2, infections" (Michigan Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,753, issued on Jan. 20, was assigned to THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Mich.).

"Cysteamine for the treatment, mitigation and prevention of coronaviral, e.g., SARS-CoV-2, infections" was invented by Jess Thoene (Ann Arbor, Mich.) and Robert Gavin (Ann Arbor, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for the treatment, mitigation, and prevention of viral infections (e.g., coronavirus infections (e.g., severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etc.), etc.) and diseases (e.g., Coronavirus disease 2019 (COVID-19)) associated therewith by the administration of cysteamine or ...